Close Menu

NEW YORK (GenomeWeb) – Danaher today initiated its 2018 outlook, saying earnings per share is anticipated to be in the range of $3.50 to $3.60.

On an adjusted basis, EPS was guided to a range of $4.25 to $4.35, which assumes revenue growth of between 3.5 percent and 4 percent, the company said. The consensus Wall Street estimate for 2018 is for EPS of $4.34.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.